Sold as Mounjaro (for diabetes) and Zepbound (for weight management), tirzepatide has quickly become the most prescribed alternative for people who want more weight loss than semaglutide delivers
Ethics declarations Ethics approval and consent to participate This article does not contain any studies with human participants or animals performed by any of the authors
No alcohol
Cardiovascular Benefits Reduces the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes
Like other GLP-1 medications, Mounjaro has been prescribed to both diabetes patients and weight loss patients, but lawsuits claim that many suffered severe side effects, including delayed gastric emptying, bowel obstruction, cyclic vomiting syndrome, and even permanent vision loss
If someone experiences side effects like stomach upset, starting with a smaller dose and slowly raising it often helps